Novel Natural Carrier‐Free Self‐Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier
Advanced Healthcare Materials · 2023-12 · 12 (31)
DOI: 10.1002/adhm.202301826 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 19.09.2023. Verfasst von Shan Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 102488, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Berberine, Nanoparticles. Die Arbeit wurde bisher 110-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Announce and be in Command Key Project in Beijing University of Traditional Chinese Medicine.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a chronic inflammatory illness affecting the colon and rectum, with current treatment methods being unable to meet the clinical needs of ulcerative colitis patients. Although nanomedicines are recognized as promising anti‐inflammatory medicines, their clinical application is limited by their high cost and unpredictable safety risks. This study reveals that two natural phytochemicals, berberine (BBR) and hesperetin (HST), self‐assemble directly to form binary carrier‐free multi‐functional spherical nanoparticles (BBR‐HST NPs) through noncovalent bonds involving electrostatic interactions, π–π stacking, and hydrogen bonding. Because of their synergistic anti‐inflammatory activity, berberine–hesperetin nanoparticles (BBR‐HST NPs) exhibit significantly better therapeutic effects on UC and inhibitory effects on inflammation than BBR and HST at the same dose by regulating the immune microenvironment and repairing the damaged intestinal barrier. Furthermore, BBR‐HST NPs exhibit good biocompatibility and biosafety. Thus, this study proves the potential of novel natural anti‐inflammatory nanoparticles as therapeutic agents for UC, which could promote the progress of drug development for UC and eventually benefit patients who suffering from it.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 102488, China.
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
- School of Life Science, Beijing University of Chinese Medicine, Beijing, 102488, China.
ORCID-Profile: Shan Gao, Shujing Xu, Haimin Lei
Förderung
- National Natural Science Foundation of China
- Announce and be in Command Key Project in Beijing University of Traditional Chinese Medicine
Zitieren
APA
Gao, S., Zheng, H., Xu, S., Kong, J., Gao, F., Wang, Z., Li, Y., Dai, Z., Jiang, X., Ding, X., & Lei, H. (2023). Novel Natural Carrier‐Free Self‐Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier. Advanced Healthcare Materials, 12(31). https://doi.org/10.1002/adhm.202301826
Vancouver
Gao S, Zheng H, Xu S, Kong J, Gao F, Wang Z, et al. Novel Natural Carrier‐Free Self‐Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier. Advanced Healthcare Materials. 2023;12(31). doi:10.1002/adhm.202301826
BibTeX
@article{Gao2023,
author = {Gao, Shan and Zheng, Haocheng and Xu, Shujing and Kong, Jingwei and Gao, Feng and Wang, Zhijia and Li, Yuan and Dai, Ziqi and Jiang, Xinqi and Ding, Xia and Lei, Haimin},
title = {Novel Natural Carrier‐Free Self‐Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {31},
doi = {10.1002/adhm.202301826}
}
EUVIMED